This inventor holds 3 USPTO granted patents. Active years: 2024-2025.
Years Active: 2024-2025
Title: Innovations by Matthew E Lochner in Skin Care Technology
Introduction
Matthew E Lochner is an innovative inventor based in Cambridge, MA (US). He has made significant contributions to the field of skin care technology through his inventive solutions. With a total of 3 patents, Lochner is at the forefront of integrating technology with health diagnostics.
Latest Patents
Lochner's latest patents include a Computer Skin Care System, AR Virtual Skin Marking and Analysis, and Holoportation - Camera and/or Other Sensor Analysis of Skin. These inventions focus on diagnosing and monitoring health conditions through advanced skin data analysis. The computer system receives skin data from users, which includes images and other relevant information. It processes this data to identify skin conditions and compare it with health indicators that may not be directly related to skin diseases. The technology allows for capturing skin data using a smartphone camera or dedicated devices, enhancing the accuracy of health assessments.
Career Highlights
Throughout his career, Lochner has demonstrated a commitment to innovation in health technology. His work has paved the way for new methods of skin analysis, which can lead to better health monitoring and diagnostics. The integration of augmented reality in his inventions marks a significant advancement in how users can interact with their skin health data.
Collaborations
Lochner has collaborated with notable individuals such as Scott Lochner and George Edwards. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
Matthew E Lochner's contributions to skin care technology exemplify the intersection of innovation and health. His patents reflect a forward-thinking approach to diagnosing and monitoring health conditions through advanced technology. The impact of his work is likely to influence the future of health diagnostics significantly.